In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isola....

<?php echo get_the_title(); ?>
Neue Suche PDF Herunterladen URSACHENMEDIZIN
Pfaller MA, Messer SA, Hollis RJ (2002)
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Antimicrob Agents Chemother 2002 June; 46(6)
pp. 1723–1727
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

Candida tropicalis, Stuhl-Isolat, Reis,400-fache Vergrößerung. Kontrast

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

Candida-parapsilosis, Ohr-Isolat, Reis, 1 Tag, 200-fach, Kontrast

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

Candida albicans, Stuhl-Isolat, Reis, 7 Tage, 630-fache Vergrößerung

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

Geotrichum candidum, Stuhl-Isolat, Reis, 4 Tage, 200-fache Vergrößerung

Ravuconazol; Voriconazol; Amphotericin B; Flucytosin (5FC); Itraconazol; Fluconazol; Candida spp.; Candida albicans; C. glabrata; C. krusei

Check-ups auf pathogene Hefen

Check-ups for pathogenic yeasts

Ursachenmedizinische Untersuchung und Behandlung krankmachender Pilzinfektionen.

KONTAKT

Wir beraten Sie gerne über die möglichen Ursachen Ihrer Beschwerden.

Unseren zentralen Normamed-Service in Berlin erreichen Sie unter

+49 30 212 34 36 300 service@normamed.com
Links
Normamed Service

© 2025 Normamed S.A..